Subsequently, we discovered that more immune cells infiltrated the tumor tissues of CRC patients in cluster-2 compared with that in cluster-1, such as Treg cells, mast cells, TAMs, CD8+ T cells, and B cells. This evidence concerns the gene CD8A and colorectal carcinoma.